يعرض 1 - 10 نتائج من 41 نتيجة بحث عن '"Diodati, L."', وقت الاستعلام: 1.19s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

    المؤلفون: Del Re M., Omarini C., Diodati L., Palleschi M., Meattini I., Crucitta S., Lorenzini G., Isca C., Fontana A., Livi L., Piacentini F., Fogli S., De Giorgi U., Danesi R.

    المساهمون: Del Re, M., Omarini, C., Diodati, L., Palleschi, M., Meattini, I., Crucitta, S., Lorenzini, G., Isca, C., Fontana, A., Livi, L., Piacentini, F., Fogli, S., De Giorgi, U., Danesi, R.

    مصطلحات موضوعية: Drug Interaction, Female, Human, Piperazine, Pyridine, Breast Neoplasm, Proton Pump Inhibitors

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35131649; info:eu-repo/semantics/altIdentifier/wos/WOS:000819873600043; volume:7; issue:1; firstpage:1; lastpage:2; journal:ESMO OPEN; http://hdl.handle.net/11380/1280340Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123984743

    الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100381Test
    http://hdl.handle.net/11380/1280340Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients.

    المؤلفون: Del Re M, Omarini C, Diodati L, Palleschi M, Meattini I, Crucitta S, Lorenzini G, Isca C, Fontana A, Livi L, Piacentini F, Fogli S, De Giorgi U, Danesi R.

    المساهمون: Del Re, M, Omarini, C, Diodati, L, Palleschi, M, Meattini, I, Crucitta, S, Lorenzini, G, Isca, C, Fontana, A, Livi, L, Piacentini, F, Fogli, S, De Giorgi, U, Danesi, R.

    مصطلحات موضوعية: PFS, breast cancer, drug-drug interaction, palbociclib, proton pump inhibitors

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34509802; info:eu-repo/semantics/altIdentifier/wos/WOS:000704803800029; volume:6; issue:5; firstpage:1; lastpage:2; journal:ESMO OPEN; http://hdl.handle.net/11380/1253159Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120344625

    الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100231Test
    http://hdl.handle.net/11380/1253159Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    239P Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

    المؤلفون: Del Re, M., Omarini, C., Diodati, L., Palleschi, M., Meattini, I., Crucitta, S., Isca, C., Fogli, S., Bleve, S., Lorenzini, G., Fontana, A., Livi, L., Piacentini, F., De Giorgi, U., Danesi, R.

    المصدر: Annals of Oncology ; volume 32, page S463-S464 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.522Test
    https://api.elsevier.com/content/article/PII:S0923753421027514?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753421027514?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    ANKRd44 gene silencing: A putative role in trastuzumab resistance in HER2-like breast cancer

    المؤلفون: Ferla M. L., Lessi F., Aretini P., Pellegrini D., Franceschi S., Tantillo E., Menicagli M., Marchetti I., Scopelliti C., Civita P., De Angelis C., Diodati L., Bertolini I., Roncella M., McDonnell L. A., Hochman J., Re M. D., Scatena C., Naccarato A. G., Fontana A., Mazzanti C. M.

    المساهمون: Ferla, M. L., Lessi, F., Aretini, P., Pellegrini, D., Franceschi, S., Tantillo, E., Menicagli, M., Marchetti, I., Scopelliti, C., Civita, P., De Angelis, C., Diodati, L., Bertolini, I., Roncella, M., Mcdonnell, L. A., Hochman, J., Re, M. D., Scatena, C., Naccarato, A. G., Fontana, A., Mazzanti, C. M.

    مصطلحات موضوعية: ANKRD44, Gene silencing, Her2+ breast cancer, LC-MS/MS, Next generation sequencing, Trastuzumab resistance

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31297336; info:eu-repo/semantics/altIdentifier/wos/WOS:000473056600001; volume:9; issue:JUN; numberofpages:15; journal:FRONTIERS IN ONCOLOGY; http://hdl.handle.net/11568/1000524Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85068974365; https://www.frontiersin.org/articles/10.3389/fonc.2019.00547/fullTest

    الإتاحة: https://doi.org/10.3389/fonc.2019.00547Test
    http://hdl.handle.net/11568/1000524Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    1932MO Ki67 expression and CDK4/6i activity: An emerging role for PIK3CA mutations in metastatic breast cancer patients

    المؤلفون: Del Re, M., Lorenzini, G., Cucchiara, F., De Angelis, C., Crucitta, S., Diodati, L., Cavallero, D., Bargagna, I., Cinacchi, P., Fratini, B., Salvadori, B., Fontana, A., Danesi, R.

    المصدر: Annals of Oncology ; volume 31, page S1093 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.1325Test
    https://api.elsevier.com/content/article/PII:S0923753420413213?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420413213?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study

    المؤلفون: Cazzaniga M., Verusio C., Ciccarese M., Fumagalli A., Sartori D., Valerio MR., Airoldi M., Moretti G., Ficorella C., Arcangeli V., Diodati L., Zambelli A., Febbraro A., Generali D., Pistelli M., Garrone O., Musolino A., Vici P., Maur M., Mentuccia L., La Verde N., Bianchi G., Artale S., Blasi L., Piezzo M., Atzori F., Turletti A., Benedetto C., Cursano M. C., Fabi A., Gebbia V., Schirone A., Palumbo R., Ferzi A., Frassoldati A., Scavelli C., Clivio L., Torri V., On behalf of The EVA Study Group

    المساهمون: Cazzaniga M., Verusio C., Ciccarese M., Fumagalli A., Sartori D., Valerio MR., Airoldi M., Moretti G., Ficorella C., Arcangeli V., Diodati L., Zambelli A., Febbraro A., Generali D., Pistelli M., Garrone O., Musolino A., Vici P., Maur M., Mentuccia L., La Verde N., Bianchi G., Artale S., Blasi L., Piezzo M., Atzori F., Turletti A., Benedetto C., Cursano M.C., Fabi A., Gebbia V., Schirone A., Palumbo R., Ferzi A., Frassoldati A., Scavelli C., Clivio L., Torri V., On behalf of The EVA Study Group

    مصطلحات موضوعية: Advanced breast cancer, Elderly, Everolimu, Exemestane, Hormone-receptor positive

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30159129; volume:9; issue:61; firstpage:31877; lastpage:31887; numberofpages:11; journal:ONCOTARGET; http://hdl.handle.net/10447/359856Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85054288051; http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&pathTest[]=25874&path[]=80859

    الإتاحة: https://doi.org/10.18632/oncotarget.25874Test
    http://hdl.handle.net/10447/359856Test
    http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&pathTest[]=25874&path[]=80859

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Expression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancer

    المؤلفون: Crucitta, S., Del Re, M., Fontana, A., Bertolini, I., Rofi, E., De Angelis, C., Diodati, L., Cavallero, D., Salvadori, B., Falcone, A., Morganti, R., Danesi, R.

    المصدر: Annals of Oncology ; volume 29, page viii46 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdy269.143Test
    https://api.elsevier.com/content/article/PII:S0923753419485712?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753419485712?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy269.143/26140410/mdy269.143.pdfTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Safety and efficacy of non-pegylated liposomal doxorubicin (NPLD) in HER2 negative metastatic breast cancer (mBC) patients (PTS) as second-line (2L) and beyond: a restrospective single institution analysis

    المؤلفون: De Angelis, C., Diodati, L., Bertolini, I., Montagnani, I., Fontana, A., Ferrarini, I., Salvadori, B., Ferrari, P., Michelotti, A., Landucci, E., Falcone, A.

    المصدر: Annals of Oncology ; volume 28, page vi42 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdx424.061Test
    https://api.elsevier.com/content/article/PII:S0923753420348006?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420348006?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/28/suppl_6/mdx424.061/21490593/mdx424.061.pdfTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Are anti-HER2 agents the best choice in metastatic breast cancer with an HER2 positive switch from primary tumour? A retrospective multi institution analysis of clinical-pathological characteristics and outcomes

    المؤلفون: Bertolini, I., Diodati, L., Fontana, A., De Angelis, C., Cantini, L., Cecconi, S., Montagnani, I., Salvadori, B., Ferrarini, I., Ferrari, P., Michelotti, A., Landucci, E., Fanelli, G., Scatena, C., Naccarato, A.G., Berardi, R., Pistelli, M., Falcone, A.

    المصدر: Annals of Oncology ; volume 28, page vi42-vi43 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdx424.064Test
    https://api.elsevier.com/content/article/PII:S0923753420348031?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420348031?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/28/suppl_6/mdx424.064/21490599/mdx424.064.pdfTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Prognostic value of lymph node ratio in early breast cancer: a restrospective single institution analysis of clinical-pathological characteristics and outcomes

    المؤلفون: Diodati, L., De Angelis, C., Bertolini, I., Montagnani, I., Salvadori, B., Ferrari, P., Fontana, A.

    المصدر: Annals of Oncology ; volume 28, page vi37-vi38 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdx424.045Test
    https://api.elsevier.com/content/article/PII:S0923753420347840?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420347840?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/28/suppl_6/mdx424.045/21490561/mdx424.045.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث